Streetbeat News

Analyst Ratings

AMPS

JP Morgan analyst Mark Strouse has maintained an Overweight rating on Altus Power (NYSE:AMPS) but reduced the price target from $8 to $7.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 6:55 pm

ZS

JP Morgan analyst Brian Essex has maintained a Neutral rating on Zscaler (NASDAQ:ZS) and increased the price target from $174 to $190.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 6:54 pm

SPHR

JP Morgan analyst David Karnovsky has maintained a Neutral rating on Sphere Entertainment (NYSE:SPHR) and increased the price target from $28 to $33.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 6:52 pm

CRWD

JP Morgan analyst Brian Essex has maintained an Overweight rating on CrowdStrike Holdings (NASDAQ:CRWD) and increased the price target from $190 to $210.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 6:51 pm

FATH

Needham analyst James Ricchiuti has maintained a Buy rating on Fathom Digital Mfg (NYSE:FATH) but has reduced the price target from $20 to $8.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 6:48 pm

LNW

Susquehanna analyst Joseph Stauff has maintained a Positive rating on Light & Wonder (NASDAQ: LNW) and increased the price target from $86 to $100.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 6:48 pm

FLT

Mizuho analyst Dan Dolev has maintained a Neutral rating on Fleetcor Technologies (NYSE:FLT) and reduced the price target from $245 to $235.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 6:47 pm

FSR

Fisker Inc (NYSE:FSR) shares dropped after reporting Q3 results, citing delivery issues due to logistical bottlenecks. Needham analyst Chris Pierce maintained a Hold rating, lowering '24 estimates due to production slowdowns to adjust inventory levels. Raymond James analyst Pavel Molchanov kept a Market Perform rating, noting intensifying competition and operational risks in scaling production. Concerns about the long-term margin profile were raised, especially since the Ocean model is ineligible for the U.S. federal tax credit. FSR shares fell 22.02% to $3.21.

Portfolio Pulse from Priya Nigam

November 14, 2023 | 6:46 pm

SABS

HC Wainwright & Co. analyst Edward White has maintained a Buy rating on SAB Biotherapeutics (NASDAQ:SABS) but has reduced the price target from $2 to $1.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 6:46 pm

LUCD

Needham analyst Mike Matson has maintained a Buy rating on Lucid Diagnostics (NASDAQ:LUCD) but has reduced the price target from $2.8 to $2.5.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 6:43 pm